Where it is registered
Each register with its number of medicines and a few of them.
Brazil
Anvisa · 1 medicine
All medicines with Rubéola
Every register, a page at a time. Strengths and packs are on each medicine’s page.
27 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Vacina Sarampo, Rubéola (Atenuada)Combination | Brazil | Authorised | Fundação Oswaldo Cruz | ||
| VACINA SARAMPO, CAXUMBA, RUBÉOLA (Atenuada)Combination | Brazil | Authorised | Fundação Oswaldo Cruz | ||
| Vacina sarampo, caxumba, rubéola e varicela (atenuada)Combination | Brazil | Authorised | Fundação Oswaldo Cruz | ||
| Vacina Contra Rubeola | Brazil | Cancelled | Fundação Oswaldo Cruz | ||
| Vacina Contra Sarampo e RubéolaCombination | Brazil | Cancelled | Sanofi-Aventis Farmacêutica Ltda | ||
| Vacina Contra Sarampo e Rubeola | Brazil | Cancelled | Sanofi Pasteur Ltda | ||
| Vacina Contra Sarampo e RubeolaCombination | Brazil | Cancelled | Glaxosmithkline Brasil Ltda | ||
| Vacina Contra Sarampo, Caxumba e RubeolaCombination | Brazil | Cancelled | Sanofi Pasteur Ltda | ||
| Vacina Contra Sarampo, Caxumba e RubeolaCombination | Brazil | Cancelled | Novartis Biociencias S.A | ||
| Vacina sarampo, caxumba e rubéola (atenuada)Combination | Brazil | Cancelled | Sanofi-Aventis Farmacêutica Ltda | ||
| M-M-Rvaxpro Polvo y Disolvente Para Suspension Inyectable en Jeringa PrecargadaCombination | Spain | 1 MILES DICT50 VIRUS + 1 MILES DICT50 VIRUS + 12,5 MILES DICT50 VIRUS | polvo y disolvente para suspensión inyectable | Marketed | Merck Sharp & Dohme B.V. |
| Priorix, Polvo y Disolvente en Jeringa Precargada Para Solución InyectableCombination | Spain | 10 MILES DICT50 VIRUS + 10 MILES DICT50 VIRUS + 10 MILES DICT50 VIRUS | polvo y disolvente para solución inyectable en jeringa precargada | Marketed | Glaxosmithkline S.A. |
| Proquad Polvo y Disolvente Para Suspension Inyectable en Jeringa PrecargadaCombination | Spain | 3 Dosis infectiva 50% en cultivo tisular + 3 Dosis infectiva 50% en cultivo tisular + 4,3 Dosis infectiva 50% en cultivo tisular + 3,99 U FIP | polvo y disolvente para suspensión inyectable | Marketed | Merck Sharp & Dohme B.V. |
| Rudivax Vacina de Virus Vivo Atenuado Contra Rubeola | Brazil | Cancelled | Sanofi Pasteur Ltda | ||
| Vacina Contra Rubeola - Virus Vivo Atenuado Liofilizado | Brazil | Cancelled | Brasvit Indústria e Comécio Ltda | ||
| Vacina Associada Contra O Sarampo, Caxumba e RubeolaCombination | Brazil | Cancelled | Prophylaxis Clinica de Vacinacao Ltda | ||
| Vacina Combinada Contra Sarampo Caxumba e Rubéola (Vírus Vivo) | Brazil | Cancelled | Glaxosmithkline Brasil Ltda | ||
| M-M-Rvaxpro Polvo y Disolvente Para Suspension InyectableCombination | Spain | 1 MILES DICT50 VIRUS + 0,01 MILES DICT50 VIRUS + 12,5 MILES DICT50 VIRUS | polvo y disolvente para suspensión inyectable | Authorised | Merck Sharp & Dohme B.V. |
| Proquad Polvo y Disolvente Para Suspension InyectableCombination | Spain | 3 Dosis infectiva 50% en cultivo tisular + 3 Dosis infectiva 50% en cultivo tisular + 4,3 Dosis infectiva 50% en cultivo tisular + 3,99 U FIP | polvo y disolvente para suspensión inyectable | Authorised | Merck Sharp & Dohme B.V. |
| M-M-R IICombination | Brazil | Authorised | Merck Sharp & Dohme Farmaceutica Ltda. | ||
| PriorixCombination | Brazil | Authorised | Glaxosmithkline Brasil Ltda | ||
| Priorix TetraCombination | Brazil | Authorised | Glaxosmithkline Brasil Ltda | ||
| ProquadCombination | Brazil | Authorised | Merck Sharp & Dohme Farmaceutica Ltda. | ||
| Priorix-Tetra Polvo y Disolvente en Jeringa Precargada Para Solucion InyectableCombination | Spain | AL MENOS103,0 Dosis infectiva 50% en cultivo celular + AL MENOS104,4 Dosis infectiva 50% en cultivo celular + AL MENOS103,0 Dosis infectiva 50% en cultivo celular + AL MENOS103,3 Unidades formadoras de placa | polvo y disolvente para solución inyectable en jeringa precargada | Suspended | Glaxosmithkline Biologicals |
| Priorix-Tetra Polvo y Disolvente Para Solucion InyectableCombination | Spain | AL MENOS103,0 Dosis infectiva 50% en cultivo celular + AL MENOS104,4 Dosis infectiva 50% en cultivo celular + AL MENOS103,0 Dosis infectiva 50% en cultivo celular + AL MENOS103,3 Unidades formadoras de placa | polvo y disolvente para solución inyectable | Withdrawn | Glaxosmithkline Biologicals |
Companies
The companies holding its medicines, the most first.
Sources
Compiled by Prognia from the public medicine registers of Anvisa. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
At a glance
- Registers
- 1
- Medicines
- 1
- Companies
- 1